Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases

Gino K. In, Kelsey Poorman, Michelle Saul, Steven O'Day, Jeffrey M. Farma, Anthony J. Olszanski, Michael S. Gordon, Jacob S. Thomas, Burton Eisenberg, Lawrence Flaherty, Amy Weise, Steven Daveluy, Geoffrey Gibney, Michael B. Atkins, Ari Vanderwalde

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

Background: Brain metastases are a significant cause of mortality and morbidity for patients with melanoma. We hypothesize that the development of brain metastases may be explained by molecular heterogeneity between primary cutaneous melanoma (PCM) or extracranial (ECM) and brain (MBM) melanoma metastases. Materials and Methods: We compared next-generation sequencing, tumor mutational burden (TMB), and immunohistochemical staining for PD-L1 expression, among 132 MBM, 745 PCM, and 1190 ECM. Results: The most common genetic alterations among MBM included: BRAF (52.4%), NRAS (26.6%), CDKN2A (23.3%), NF1 (18.9%), TP53 (18%), ARID2 (13.8%), SETD2 (11.9%), and PBRM1 (7.5%). Four genes were found with higher frequency among MBM compared to PCM or ECM: BRAF (52.4% v 40.4% v 40.9%), SETD2 (11.9% v 1.9% v 3.9%), PBRM1 (7.5% v 1.6% v 2.6%), and DICER1 (4.4% v 0.6% v 0.4%). MBM showed higher TMB (p =.04) and higher PD-L1 expression (p =.002), compared to PCM. PD-L1 expression was slightly higher among MBM compared to ECM (p =.042), but there was no difference between TMB (p =.21). Conclusions: Our findings suggest a unique molecular profile for MBM, including higher rates of BRAF mutations, higher TMB and higher PD-L1 expression, and also implicate chromatin remodeling in the pathogenesis of MBM.

Original languageEnglish
Pages (from-to)3118-3128
Number of pages11
JournalOncotarget
Volume11
Issue number33
DOIs
StatePublished - Aug 18 2020

Keywords

  • BRAF
  • Brain metastases
  • Melanoma
  • PD-L1
  • TMB

Fingerprint

Dive into the research topics of 'Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases'. Together they form a unique fingerprint.

Cite this